NDC 55150-315 – Succinylcholine Chloride
Succinylcholine Chloride 20 mg/mL · Injection, Solution · Intramuscular, Intravenous
Product NDC55150-315
Product details
- Brand name
- Succinylcholine Chloride
- Generic name
- Succinylcholine chloride
- Labeler
- Eugia US LLC
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA217808
- Marketed since
- October 16, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Depolarizing Neuromuscular Blocker
Active ingredients
- Succinylcholine Chloride 20 mg/mL
Uses, dosage, side effects and warnings for Succinylcholine Chloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-315-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (55150-315-25) / 10 mL in 1 VIAL, MULTI-DOSE (55150-315-01) | Oct 16, 2023 |
Other Succinylcholine Chloride products
- 43066-127 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 43066-129 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 71839-121 Succinylcholine Chloride 20 mg/mL · Injection, Solution · BE Pharmaceuticals Inc.
- 31722-981 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Camber Pharmaceuticals, Inc.
- 73043-021 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Devatis, Inc.
- 65219-274 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Fresenius Kabi USA LLC
- 65219-276 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Fresenius Kabi USA LLC
- 63323-943 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68083-450 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Gland Pharma Limited
- 0404-9983 Succinylcholine Chloride 20 mg/mL · Injection, Solution · Henry Schein, Inc.
- 51662-1525 Succinylcholine Chloride 20 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 0143-9338 Succinylcholine Chloride Dihydrate 20 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.